Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

When measured against the market's most prolific capital-return leaders, Amgen’s ability to maintain this level of ...

On February 17, 2026, Amgen Inc. issued and sold a total of $4 billion in senior unsecured notes across four tranches maturing between 2031 and 2056, carrying coupons ranging from 4.200% to 5.650%.

What Does Amgen's Recent Share Price Action Mean For Its Valuation? Amgen's share price can tell you a lot about what the market thinks it is worth, but the real question is whether that price still ...

Amgen’s AMGN stock has risen almost 16% in a month. A lot of this price increase is due to strong third-quarter 2025 results, wherein both the top and bottom lines exceeded expectations. Amgen also ...

Compared to the aggregate P/E ratio of the 83.91 in the Biotechnology industry, Amgen Inc. has a lower P/E ratio of 26.69. Shareholders might be inclined to think that the stock might perform worse ...

On Tuesday, Amgen (NASDAQ: AMGN) stock hit its one-year high, on continued momentum from a far better-than-expected quarterly earnings report. The immediate catalyst was a post-earnings price target ...

Murdo Gordon, EVP at Amgen (NASDAQ:AMGN), executed a substantial insider sell on November 14, according to an SEC filing. What Happened: According to a Form 4 filing with the U.S. Securities and ...